Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01024946
Brief Title: Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

First Submitted : December 2, 2009
First Submitted that Met QC Criteria : December 2, 2009
First Posted : December 3, 2009 (Estimate)

Results First Submitted : April 7, 2015
Results First Submitted that Met QC Criteria : April 7, 2015
Results First Posted : April 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 21, 2015
Last Update Posted : May 12, 2015 (Estimate)